MCID: RCT018
MIFTS: 53

Rectal Neoplasm

Categories: Cancer diseases, Gastrointestinal diseases

Aliases & Classifications for Rectal Neoplasm

MalaCards integrated aliases for Rectal Neoplasm:

Name: Rectal Neoplasm 12 14
Rectal Carcinoma 52 69
Rectal Neoplasms 42 69
Rectum Cancer 12 14
Rectal Cancer 12 52
Malignant Neoplasm of Rectum 12
Malignant Tumor of Rectum 12
Malignant Rectal Neoplasm 69
Adenocarcinoma of Rectum 69
Carcinoma of the Rectum 12
Malignant Rectal Tumor 12
Malignant Rectum Tumor 12
Neoplasm of the Rectum 29
Carcinoma of Rectum 12
Neoplasm of Rectum 12
Cancer of Rectum 12
Rectum Neoplasm 12
Rectal Tumors 69
Rectal Tumor 12

Classifications:



Summaries for Rectal Neoplasm

Disease Ontology : 12 A colorectal cancer that is located in the rectum.

MalaCards based summary : Rectal Neoplasm, also known as rectal carcinoma, is related to colorectal cancer and rectum sarcoma. An important gene associated with Rectal Neoplasm is TYMS (Thymidylate Synthetase), and among its related pathways/superpathways are Pathways in cancer and DNA Damage. The drugs Erbitux and Iron have been mentioned in the context of this disorder. Affiliated tissues include prostate, colon and liver, and related phenotype is neoplasm.

Wikipedia : 72 Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from... more...

Related Diseases for Rectal Neoplasm

Diseases related to Rectal Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 200)
id Related Disease Score Top Affiliating Genes
1 colorectal cancer 27.5 CEACAM5 DPYD HRAS KRAS KRT20 KRT7
2 rectum sarcoma 25.1 APAF1 APBA2 CAGE1 CEACAM5 DPYD HRAS
3 rectal cancer, childhood 11.9
4 deep angioma 10.9 CEACAM5 TP53
5 large intestine adenocarcinoma 10.8 MLH1 MSH2
6 optic nerve sheath meningioma 10.8 MLH1 MSH2
7 intestine carcinoma in situ 10.8 CEACAM5 SMUG1
8 ureter squamous cell carcinoma 10.8 CEACAM5 SMUG1
9 monieziasis 10.8 CEACAM5 SMUG1
10 mixed oligodendroglioma-astrocytoma 10.8 CEACAM5 TP53
11 lynch syndrome 10.8
12 limb ischemia 10.8 HRAS KRAS
13 rectum adenocarcinoma 10.8
14 malignant skin fibrous histiocytoma 10.7 CEACAM5 HRAS KRAS
15 acute cholinergic dysautonomia 10.7 MSH2 TP53
16 gastric papillary adenocarcinoma 10.7 CEACAM5 HRAS KRAS
17 pyloric antrum cancer 10.7 CEACAM5 MLH1 TYMP
18 benign fibrous mesothelioma 10.7 MLH1 MSH2
19 tabes dorsalis 10.7 HRAS KRAS KRT20
20 rheumatic pulmonary valve disease 10.7 CEACAM5 HRAS KRAS
21 appendix adenocarcinoma 10.7 CEACAM5 HRAS KRAS
22 psoriasis 10.7 MLH1 MSH2
23 pulmonary embolism and infarction 10.7 SMUG1 TP53
24 hereditary nephrotic syndromes, autosomal dominant 10.7 KRAS MLH1 MSH2
25 choriocarcinoma 10.7 KRT20 TP53 TYMP
26 breast myoepithelial neoplasm 10.7 KRAS TP53
27 factor xiii deficiency 10.7 MSH2 SMUG1
28 cataract 27, nuclear progressive 10.7 MLH1 MSH2
29 severe pre-eclampsia 10.7 HRAS KRAS
30 familial lipoprotein lipase deficiency 10.7 KRAS SLC14A2 SMUG1
31 coloboma of inferior eyelid 10.7 KRAS TP53
32 hypersensitivity reaction type iii disease 10.6 HRAS KRAS TP53
33 malignant syringoma 10.6 KRAS SMUG1 TP53
34 advanced sleep phase syndrome 10.6 HRAS KRAS TP53
35 ossifying fibromyxoid tumor 10.6 HRAS KRAS TP53
36 familial episodic pain syndrome 10.6 MLH1 MSH2 TP53
37 melanocytic nevus syndrome, congenital, somatic 10.6 HRAS MLH1 MSH2
38 bone giant cell tumor 10.6 KRT20 KRT7
39 split hand split foot nystagmus 10.6 HRAS TP53
40 olfactory neuroblastoma 10.6 HRAS KRAS TP53
41 seminal vesicle chronic gonorrhea 10.6 HRAS KRAS SMUG1
42 hand dermatosis 10.6 MLH1 MSH2 TP53
43 chronic polyneuropathy 10.6 HRAS SMUG1
44 cellular myxoid liposarcoma 10.6 MLH1 MSH2 TP53
45 rectum adenoma 10.6 KRT20 KRT7
46 mucoepidermoid thyroid carcinoma 10.6 CEACAM5 KRT7
47 breast cystic hypersecretory carcinoma 10.6 CEACAM5 KRT7
48 transient neonatal thrombocytopenia 10.6 CEACAM5 SMUG1 TP53
49 multiple carboxylase deficiency 10.6 SMUG1 TP53 TYMP
50 periosteal osteogenic sarcoma 10.6 KRT20 KRT7

Comorbidity relations with Rectal Neoplasm via Phenotypic Disease Network (PDN): (show all 12)


Active Peptic Ulcer Disease Acute Cystitis
Anus Cancer Colorectal Cancer
Deficiency Anemia Hydronephrosis
Intestinal Obstruction Neutropenia
Paralytic Ileus Protein-Energy Malnutrition
Rectosigmoid Junction Neoplasm Rectum Carcinoma in Situ

Graphical network of the top 20 diseases related to Rectal Neoplasm:



Diseases related to Rectal Neoplasm

Symptoms & Phenotypes for Rectal Neoplasm

MGI Mouse Phenotypes related to Rectal Neoplasm:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 9.23 TP53 APAF1 HRAS KRAS MLH1 MMP7

Drugs & Therapeutics for Rectal Neoplasm

FDA approved drugs:

id Drug Name Active Ingredient(s) 17 Company Approval Date
1
Erbitux 17 46 CETUXIMAB Imclone, Bristol-Myers Squibb February 2004

Drugs for Rectal Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 667)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Iron Approved Phase 4 7439-89-6 23925
2
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 61825-94-3 5310940 9887054 43805 6857599
3
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1 51-21-8 3385
4
Tegafur Approved Phase 4,Phase 3,Phase 2,Phase 1 17902-23-7 5386
5
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
6
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 437-38-7 3345
7
Capecitabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 154361-50-9 60953
8
Irinotecan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 97682-44-5, 100286-90-6 60838
9
Levoleucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1 68538-85-2
10
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2 2078-54-8 4943
11
Bevacizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 216974-75-3
12
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-02-2 5743
13
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 169590-42-5 2662
14
Ertapenem Approved, Investigational Phase 4 153832-46-3 150610
15
Udenafil Approved, Investigational Phase 4,Phase 2 268203-93-6 6918523
16
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
17
Darbepoetin alfa Approved, Investigational Phase 4 11096-26-7, 209810-58-2
18
Cefuroxime Approved Phase 4 55268-75-2 5361202 5479529
19
Metronidazole Approved Phase 4,Phase 2,Phase 3,Phase 1 443-48-1 4173
20
Sulfamethoxazole Approved Phase 4 723-46-6 5329
21
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
22
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
23
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1 2216-51-5 16666
24
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
25
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
26
Guaifenesin Approved, Vet_approved Phase 4,Phase 2 93-14-1 3516
27
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2 137-58-6 3676
28
Morphine Approved, Investigational Phase 4,Phase 3 57-27-2 5288826
29
Amoxicillin Approved, Vet_approved Phase 4,Phase 2 26787-78-0 33613 2171
30
Ciprofloxacin Approved, Investigational Phase 4,Phase 2 85721-33-1 2764
31
Dopamine Approved Phase 4,Phase 2 51-61-6, 62-31-7 681
32
Acetaminophen Approved Phase 4 103-90-2 1983
33
Hydrocodone Approved, Illicit Phase 4 125-29-1 5284569
34
Hydromorphone Approved, Illicit Phase 4 466-99-9 5284570
35
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
36
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
37
Methadone Approved Phase 4 76-99-3 4095
38
Orphenadrine Approved Phase 4 83-98-7 4601
39
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
40
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
41
Cobicistat Approved Phase 4 1004316-88-4
42
Efavirenz Approved, Investigational Phase 4 154598-52-4 64139
43
Emtricitabine Approved, Investigational Phase 4 143491-57-0 60877
44
Levofloxacin Approved, Investigational Phase 4,Phase 3 100986-85-4 149096
45
Ofloxacin Approved Phase 4,Phase 3 82419-36-1 4583
46
Levobupivacaine Approved Phase 4 27262-47-1 92253
47
Fosfomycin Approved Phase 4 23155-02-4 446987
48
Granisetron Approved, Investigational Phase 4 109889-09-0 3510
49
Metoclopramide Approved, Investigational Phase 4 364-62-5 4168
50
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1 58-05-9 143 6006

Interventional clinical trials:

(show top 50) (show all 2175)

id Name Status NCT ID Phase Drugs
1 Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate. Unknown status NCT00199277 Phase 4 i.v. iron sucrose;Oral iron
2 Trial on Mechanical Bowel Preparation in Laparoscopic Colorectal Surgery Unknown status NCT01797770 Phase 4 polyethylene glycol
3 Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer Unknown status NCT00274885 Phase 4 oxaliplatin
4 Trial to Reduce Wound Infection With Contralateral Drainage in Loop Ileostomy Closure Unknown status NCT02574702 Phase 4
5 Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer Unknown status NCT01972503 Phase 4 5-FU and oxaliplatin
6 The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin Unknown status NCT01549418 Phase 4 Aspirin (ASA);Placebo
7 Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer Completed NCT01912586 Phase 4
8 Concentration of Ertapenem in Colorectal Tissue Completed NCT00535652 Phase 4 Ertapenem
9 Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection Completed NCT01722565 Phase 4
10 The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer Completed NCT01421940 Phase 4 Placebo drug;Udenafil
11 NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery Completed NCT01056913 Phase 4
12 Prospective Randomized Study of SILS Versus CLS for Rectal Cancer Completed NCT01579721 Phase 4
13 The Effect of Dexmedetomidine on Postoperative Analgesia Completed NCT01373021 Phase 4 Fentanyl;Dexmedetomidine
14 CHOICE: Communicating Health Options Through Information and Cancer Education Completed NCT00134589 Phase 4
15 The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery Completed NCT00122720 Phase 4 Darbepoetin Alfa
16 Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer Completed NCT00559676 Phase 4 capecitabine;fluorouracil;irinotecan hydrochloride;leucovorin calcium;oxaliplatin
17 Orally Administered Trimethoprim-sulfamethoxazole and Metronidazole as Prophylaxis of Infection Following Elective Colorectal Surgery Completed NCT00613769 Phase 4 trimethoprim-sulfamethoxazole + metronidazole;cefuroxime and metronidazole
18 I Phase Surgery Versus Staged Surgery for Synchronous Liver Metastasis of Colorectal Cancer Completed NCT00677586 Phase 4
19 Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants Completed NCT00138060 Phase 4 irinotecan;5 fluorouracil
20 Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients Completed NCT01732783 Phase 4
21 Dissemination of Colorectal Cancer Screening to Primary Care Physicians Completed NCT00441311 Phase 4
22 Oxidative Stress Markers in Open and Laparoscopic Colectomy for Cancer Completed NCT00928928 Phase 4
23 Transanal Endoscopic Microsurgery Versus Endoscopic Submucosal Dissection For Large Rectal Adenomas Recruiting NCT01023984 Phase 4
24 Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane Anesthesia Recruiting NCT01975064 Phase 4 Propofol;Sevoflurane
25 Study of NOTES-TME Versus L-LAR in Rectal Cancer Recruiting NCT02550769 Phase 4
26 Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery Recruiting NCT02958566 Phase 4 Acetaminophen;Gabapentin;Orphenadrine;Lidocaine;Marcaine;Ketamine;Methadone;Tramadol;Ketorolac;Morphine Sulfate;Fentanyl;Dilaudid;Hydrocodone-Acetaminophen Tab 5-325 MG;Morphine Sulfate;Fentanyl;Dilaudid;HYDROCODONE/ACETAMINOPHEN 5 Mg-325 Mg ORAL TABLET
27 HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women Recruiting NCT01815580 Phase 4 Atripla or Stribild
28 Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer Recruiting NCT02757365 Phase 4 aspirin;Levofloxacin
29 Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases Recruiting NCT02015923 Phase 4 Chemotherapy- scheme
30 Efficacy of Rectal Sheath Analgesia After Midline Laparotomy Active, not recruiting NCT02869841 Phase 4 Levobupivacaine continuous infusion;levobupivacaine bolus dosing;single bolus of levobupivacaine
31 Ohio Patient Navigator Research Program Active, not recruiting NCT01569672 Phase 4
32 Efficacy of an Onlay Mesh for Prevention of Incisional Hernia After Loop Ileostomy Closure Not yet recruiting NCT02896686 Phase 4
33 Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. Not yet recruiting NCT03228108 Phase 4 Ciprofloxacin;Trimethoprim/Sulfamethoxazole;Fosfomycin;Pivmecillinam/augmentin
34 Treatment Algorithm for Nausea and Vomiting in the Palliative Phase Not yet recruiting NCT03017391 Phase 4 metoclopramide;granisetron;Dexamethasone;Granisetron 2Mg Tablet
35 Radial Reload Laparoscopic LAR Case Series Terminated NCT01706822 Phase 4
36 Dissemination of Cervical Cancer Screening to Primary Care Physicians in Underserved Communities Terminated NCT00629993 Phase 4
37 Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma Terminated NCT00216424 Phase 4 Capecitabine (Xeloda)
38 Dissemination of Prostate Cancer Screening to PCP's in African American Communities Terminated NCT00629330 Phase 4
39 A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED) Terminated NCT00140894 Phase 4 MK0966; rofecoxib / Duration of Treatment: 24 weeks;Comparator: placebo / Duration of Treatment: 24 weeks
40 Ischemic Conditioning (Delay Phenomenon) in Colorectal Surgery Terminated NCT00887497 Phase 4
41 Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients Terminated NCT00151476 Phase 4 Celecoxib
42 A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer Terminated NCT00114946 Phase 4 Avastin
43 Short Term Outcomes of Laparoscopic Intersphincteric Resection for Low Rectal Cancer Unknown status NCT01836926 Phase 2, Phase 3
44 Randomized Prospective Trial for Laparoscopic vs Open Resection for Rectal Cancer Unknown status NCT00470951 Phase 3
45 Preoperative Radiotherapy and Local Excision in Rectal Cancer Unknown status NCT00738790 Phase 3
46 The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer Unknown status NCT00833131 Phase 3
47 Simultaneous Integrated Boost Preoperative Radiotherapy for Rectum Cancer Unknown status NCT01224392 Phase 3
48 A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Unknown status NCT01064999 Phase 2, Phase 3 Oxaliplatin;Capecitabine
49 Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer Unknown status NCT00597311 Phase 3
50 COLOR II: Laparoscopic Versus Open Rectal Cancer Removal Unknown status NCT00297791 Phase 3

Search NIH Clinical Center for Rectal Neoplasm

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: rectal neoplasms

Genetic Tests for Rectal Neoplasm

Genetic tests related to Rectal Neoplasm:

id Genetic test Affiliating Genes
1 Neoplasm of the Rectum 29

Anatomical Context for Rectal Neoplasm

MalaCards organs/tissues related to Rectal Neoplasm:

39
Prostate, Colon, Liver, Testes, Lung, Lymph Node, T Cells

Publications for Rectal Neoplasm

Articles related to Rectal Neoplasm:

(show all 15)
id Title Authors Year
1
Pancreatic solid pseudopapillary neoplasm as an incidental discovery in a patient with rectal neoplasm. ( 28338106 )
2017
2
Endoscopic submucosal dissection of an unusual flat rectal neoplasm. ( 25320106 )
2014
3
Images of the month: heterotopic gastric mucosa mimicking rectal neoplasm on colonoscopy. ( 23552305 )
2013
4
Hybrid transanal endoscopic microsurgery: a novel approach to rectal neoplasm excision. ( 24118673 )
2013
5
Phantom rectum following abdominoperineal excision for rectal neoplasm: appearance and disappearance. ( 23746116 )
2013
6
Excision of a rectal neoplasm using robotic transanal surgery (RTS): a description of the technique. ( 22584407 )
2012
7
The significant rectal neoplasm and mucosectomy by transanal endoscopic microsurgery (Br J Surg 2011; 98: 1342-1344). ( 21887781 )
2011
8
Postradiotherapy regression--a prognostic factor in rectal neoplasm. ( 22308912 )
2011
9
The significant rectal neoplasm and mucosectomy by transanal endoscopic microsurgery. ( 21633951 )
2011
10
Solitary rectal ulcer syndrome mimicking rectal neoplasm on MRI. ( 20965892 )
2010
11
Early outcomes of 100 patients with laparoscopic resection for rectal neoplasm. ( 15931488 )
2004
12
Mass screening for rectal neoplasm in Jiashan County, China. ( 1753269 )
1991
13
Pre-operative staging of rectal neoplasm and its impact on clinical management. ( 4063751 )
1985
14
Granular-cell myoblastoma--an unusual rectal neoplasm. Report of a case. ( 4304580 )
1969
15
Sigmoidorectal prolapse simulating rectal neoplasm. ( 13871441 )
1962

Variations for Rectal Neoplasm

Copy number variations for Rectal Neoplasm from CNVD:

7
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 139647 2 185171337 185512459 Copy number ZNF804A Rectal cancer
2 166960 3 1109627 1420278 Copy number CNTN6 Rectal cancer
3 225401 7 45400000 54000000 Copy number EGFR Rectal cancer

Expression for Rectal Neoplasm

Search GEO for disease gene expression data for Rectal Neoplasm.

Pathways for Rectal Neoplasm

GO Terms for Rectal Neoplasm

Biological processes related to Rectal Neoplasm according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 Ras protein signal transduction GO:0007265 9.58 HRAS KRAS TP53
2 determination of adult lifespan GO:0008340 9.48 MSH2 TP53
3 pyrimidine nucleoside catabolic process GO:0046135 9.46 DPYD TYMP
4 positive regulation of isotype switching to IgG isotypes GO:0048304 9.43 MLH1 MSH2
5 response to isolation stress GO:0035900 9.37 HRAS KRAS
6 pyrimidine nucleobase metabolic process GO:0006206 9.32 TYMP TYMS
7 somatic recombination of immunoglobulin gene segments GO:0016447 9.26 MLH1 MSH2
8 positive regulation of isotype switching to IgA isotypes GO:0048298 9.16 MLH1 MSH2
9 intrinsic apoptotic signaling pathway GO:0097193 9.13 APAF1 HRAS TP53
10 somatic recombination of immunoglobulin genes involved in immune response GO:0002204 8.62 MLH1 MSH2

Molecular functions related to Rectal Neoplasm according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 mismatched DNA binding GO:0030983 8.96 MLH1 MSH2
2 guanine/thymine mispair binding GO:0032137 8.62 MLH1 MSH2

Sources for Rectal Neoplasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....